Page last updated: 2024-09-05

avasimibe and Body Weight

avasimibe has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Wit, EC; Delsing, DJ; Gijbels, MJ; Havekes, LM; Jukema, JW; Offerman, EH; Princen, HM; van Der Boom, H; van Der Laarse, A; van Duyvenvoorde, W	1

Other Studies

1 other study(ies) available for avasimibe and Body Weight

Article	Year
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE3-Leiden mice. Circulation, 2001, Apr-03, Volume: 103, Issue:13* Topics: Acetamides; Acetates; Animals; Anticholesteremic Agents; Aortic Valve; Apolipoprotein E3; Apolipoproteins E; Arteriosclerosis; Body Weight; Cell Adhesion; Cell Line; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Eating; Endothelium, Vascular; Female; Heterozygote; Lipoproteins; Macrophages; Mice; Mice, Transgenic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids	2001

Article

Year

Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.

Circulation, 2001, Apr-03, Volume: 103, Issue:13

Topics: Acetamides; Acetates; Animals; Anticholesteremic Agents; Aortic Valve; Apolipoprotein E3; Apolipoproteins E; Arteriosclerosis; Body Weight; Cell Adhesion; Cell Line; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Eating; Endothelium, Vascular; Female; Heterozygote; Lipoproteins; Macrophages; Mice; Mice, Transgenic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids

2001